Related references
Note: Only part of the references are listed.Effects of bromocriptine on Parkinsonism A nation-wide collaborative double-blind study
Yasuo Toyokura et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease
C. Warren Olanow
NEUROLOGY (2006)
Excessive daytime sleepiness in Parkinson's disease
AH Schapira
NEUROLOGY (2004)
The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease - Final results of a 5-year, double-blind, Levodopa-controlled study
F Bracco et al.
CNS DRUGS (2004)
Slowing Parkinson's disease progression - Recent dopamine agonist trials
JE Ahlskog
NEUROLOGY (2003)
An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines
CW Olanow et al.
NEUROLOGY (2001)
Share Paper
